28 studies found for:    " July 06, 2011":" August 05, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Physiologic Investigation of the Renin Angiotensin Aldosterone Axis in HIV
Condition: HIV-infection
Intervention: Drug: Angiotensin II Infusion
2 Completed Post-marketing Safety Surveillance Program in Human Immunodeficiency Virus (HIV)-Infected Children Exposed to Atazanavir in Europe
Condition: HIV Infection
Intervention:
3 Completed A Safety Study Of A Single Vaginal Administration Of P2G12 Antibody In Healthy Female Subjects
Condition: Human Immunodeficiency Virus
Intervention: Drug: P2G12
4 Recruiting Connect to Protect (C2P): Building a Community-Based Infrastructure for HIV Prevention
Condition: HIV Infection
Intervention: Behavioral: Community Mobilization
5 Recruiting Allogeneic Transplant in HIV Patients (BMT CTN 0903)
Conditions: Leukemia;   Lymphoma;   HIV
Interventions: Drug: Fludarabine and Busulfan;   Drug: Fludarabine and Melphalan;   Drug: Busulfan and Fludarabine;   Drug: Cyclophosphamide and Total Body Irradiation
6 Completed Moringa Oleifera- Antiretroviral Pharmacokinetic Drug Interaction
Condition: HIV
Intervention: Dietary Supplement: Moringa oleifera
7 Recruiting Connect 'n Unite: Couples-Based HIV/STI Prevention for Drug-Involved, Black MSM
Conditions: HIV;   Sexually Transmitted Infections
Interventions: Behavioral: CNU Intervention;   Behavioral: WP Intervention
8 Completed Safety and Immunogenicity Study of a DNA Priming and MVA Boosting Strategy of HIV Vaccine
Condition: HIV Infections
Interventions: Biological: DNA HIVIS and MVA-CMDR;   Biological: Saline solution
9 Unknown  Depression and ART Adherence in HIV+ Latinos
Conditions: Depressive Symptoms;   HIV Infections
Intervention: Behavioral: Cognitive-Behavioral Therapy AD
10 Withdrawn Impact of Menstrual Cycle on Antiretroviral Pharmacokinetics in HIV-Infected Women
Condition: HIV Infected
Intervention: Drug: Tenofovir, Emtricitabine, Atazanavir, Ritonavir
11 Unknown  Stanford Universities: The Stanford HIV Aging Cohort
Condition: Acquired Immunodeficiency Syndrome
Intervention:
12 Completed HIV Prevention and Care of Psychological Trauma in Vulnerable Rwandan Youth
Conditions: Acquired Immunodeficiency Syndrome;   Stress Disorders, Post-Traumatic
Intervention: Behavioral: Questionnaires
13 Recruiting Eplerenone in HIV Associated Abdominal Fat Accumulation
Condition: HIV
Interventions: Drug: Eplerenone and lifestyle;   Other: placebo and lifestyle
14 Active, not recruiting Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care
Condition: HIV-infection/Aids
Intervention: Behavioral: Health Navigator
15 Completed Increasing Viral Testing in the Emergency Department
Conditions: Drug Use;   HIV;   Hepatitis C
Intervention: Behavioral: Brief motivational intervention
16 Recruiting Integrated Stepped Care for Unhealthy Alcohol Use in HIV
Conditions: Liver Diseases, Alcoholic;   Alcoholism;   HIV;   Hepatitis C
Interventions: Other: Integrated Stepped Care (ISC);   Other: Treatment as Usual
17 Completed
Has Results
Taste Assessment Study of 2 Atazanavir Powder Formulations in Healthy Subjects
Condition: HIV
Interventions: Drug: Atazanavir (current formulation);   Drug: Atazanavir, powder for oral use 1  (POU1);   Drug: Atazanavir (POU2)
18 Unknown  Integrated Treatment for Smoking Cessation & Anxiety in People With HIV Phase 1
Conditions: Nicotine Dependence;   Symptoms of Anxiety;   HIV
Intervention: Behavioral: Integrated cognitive-behavioral therapy for smoking cessation and anxiety
19 Active, not recruiting Adolescent Master Protocol
Condition: HIV/AIDS
Intervention:
20 Unknown  Centralized Off-Site Adherence Enhancement Program
Condition: HIV/AIDS
Intervention: Behavioral: cognitive-behavioral therapy

   Previous Page Studies Shown (1-20) Next Page (21-28) Show next page of results    Last Page
Indicates status has not been verified in more than two years